Gainers
- PLx Pharma (NASDAQ:PLXP) stock increased by 10.6% to $0.23 during Wednesday's after-market session. The market value of their outstanding shares is at $6.5 million.
- Clovis Oncology (NASDAQ:CLVS) shares rose 9.76% to $0.12. Trading volume for this security closed at 5.4 million, accounting for 125.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.7 million.
- OpGen (NASDAQ:OPGN) stock increased by 9.09% to $0.18. Today's trading volume for this security ended up closing at 2.9 million shares, which is 72.0 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $9.6 million.
- Champions Oncology (NASDAQ:CSBR) shares rose 8.26% to $4.98. The market value of their outstanding shares is at $67.3 million. The company's, Q2 earnings came out yesterday.
- Humanigen (NASDAQ:HGEN) stock moved upwards by 8.18% to $0.14. At the close, Humanigen's trading volume reached 120.5K shares. This is 3.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $16.3 million.
- Owlet (NYSE:OWLT) shares rose 6.78% to $0.71. The market value of their outstanding shares is at $81.5 million.
Losers
- Novavax (NASDAQ:NVAX) shares fell 13.3% to $14.94 during Wednesday's after-market session. This security traded at a volume of 598.6K shares come close, making up 11.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.
- Intelligent Bio Solutions (NASDAQ:INBS) shares decreased by 8.5% to $0.32. The market value of their outstanding shares is at $5.8 million.
- Vallon Pharmaceuticals (NASDAQ:VLON) shares declined by 6.8% to $0.48. Vallon Pharmaceuticals's trading volume hit 21.2 million shares by close, accounting for 4115.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.1 million.
- TransCode Therapeutics (NASDAQ:RNAZ) stock declined by 5.85% to $0.43. The company's market cap stands at $5.5 million.
- ImmuCell (NASDAQ:ICCC) stock fell 5.01% to $6.26. The company's market cap stands at $48.4 million.
- Vincerx Pharma (NASDAQ:VINC) stock declined by 5.0% to $0.83. Trading volume for this security closed at 541.7K, accounting for 274.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.5 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
